Global Astringent Market Professional Survey Report 2019

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
In 2018, North America is expected to account for the largest share of the global astringent market. The astringent market in North America is well-established, with the US being a major market in this region. Growth in the North American market is majorly driven by the growing geriatric population and increasing number of surgeries in the region.

The global Astringent market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Astringent volume and value at global level, regional level and company level. From a global perspective, this report represents overall Astringent market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Astringent in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Astringent manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom’Up SAS

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Thrombin-based astringent
Oxidized regenerated cellulose based astringent
Combination astringent
Gelatin-based astringent
Collagen-based astringent

Segment by Application
Hospitals
Surgical Centers
Nursing Homes